Abstract

ANTIVIRAL DRUG NEXT FOR PANDEMIC: A REVIEW

*Purabi Saha, Roshan Kumar, Gore Shraddha Raj Kumar, Rathod Shalini Shankar, Akash Kawale, Shahbaz Sikandar Nadaf, Amle Vandana Sonaji, Prodip Roy, and Subhasish Dutta

ABSTRACT

Antiviral medicines are a family of medicines to treat viral infections. Antiviral medications are known as antiviral medications. Viruses are one of the main pathogenic agents in humans, animals, and plants, causing many devastating diseases. Viruses cause various human diseases, from ailments that solve themselves to acute lethal illnesses. The development of antiviral medicine tactics focuses on two basic approaches: targeting the viruses or the host cell factors. A few herpesvirus medicines, many for influenza, and several novel antiviral medicines are available to treat hepatitis C and HIV. The antiviral drug action mechanism consists of its transition to triphosphate following the suppression of the viral DNA synthesis. There are now just 10 of the more than 220 viruses known to Infect humans available clinically licensed antiviral medicines. The outbreak of SARS-CoV-2 has highlighted the urgent need for chemicals that can mobilize fast to treat reemerging or emerging viral illnesses while developing vaccines. We evaluate the current state of RNA-focused antiviral therapy, highlight antiviral drug discovery methodologies and explore the obstacles; This study will examine antiviral medicines currently utilized, action mechanisms, and antiviral medications against COVID-19.

Keywords: ANTIVIRALS DRUGS, INHIBITORS, VIRAL INFECTION DISEASE.